Saturday, October 3, 2026
ExploreSearch
Via News
MarketCommodities

Platinum Futures Went Up By Over 7% In The Last 10 Sessions

ViaNews Editorial Team

August 29, 2023

Platinum Futures Went Up By Over 7% In The Last 10 Sessions

(VIANEWS) - Platinum (PL) has been up by 7.28% for the last 10 sessions. At 23:51 EST on Monday, 28 August, Platinum (PL) is $975.40.

Volume

Today's last reported volume for Platinum is 2083, 99.99% below its average volume of 9535355463.46.

Volatility

Platinum's last week, last month's, and last quarter's current intraday variation average was 0.81%, 0.58%, and 1.15%, respectively.

Platinum's highest amplitude of average volatility was 0.81% (last week), 1.04% (last month), and 1.15% (last quarter), respectively.

Commodity Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Platinum's commodity is considered to be oversold (<=20).

News about

  • Crude oil forecast: continues to show volatility - 28 August 2023. According to DailyForex on Monday, 28 August, "In summary, the WTI Crude Oil market's recent rally could potentially overshadow Jerome Powell's impact, thanks to various situational intricacies. "

More news about Platinum (PL).

Categories

MarketCommodities

Tags

CommodityCommoditiesFuturesPLPlatinumPrice UpCommodities Price UpCommodities Now
ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI-Driven Drug Development Meets Biotech Deal-Making and Regulatory Catalysts
AI-designed therapeutics (Insilico's rentosertib showing biological-age reductions) are moving into the clinical mainstream. Large-cap biotech is simultaneously reallocating capital through M&A (Lilly–Merida, $2.9B) and government funding (BARDA–Basilea), while trial failures (ziltivekimab, a 9.4% Novo Nordisk share drop) and upcoming FDA catalysts (the ivonescimab PDUFA on 2026-11-14) drive volatility. The wider AI regulatory and legal climate (Tesla Cybercab probe, xAI's Minnesota loss, OpenAI suits) is tightening, though QAIAx's micro-cap trial claims are speculative and weakly connected.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,327 source documents archived
Query this data → isubstrate.com